Gaiane Demirdjian1, Stephanie Bord2, Caroline Lejeune3, Ryan Masica4, Dominique Rivière5, Lucie Nicouleau6, Philippe Denizot7, Pierre-Yves Marquet8. 1. Beckman Coulter, Inc., Diagnostic Division 130, avenue de Lattre de Tassigny, Marseille 13009, France. Electronic address: gdemirdjian@beckman.com. 2. Beckman Coulter, Inc., Diagnostic Division 130, avenue de Lattre de Tassigny, Marseille 13009, France. Electronic address: sbord@beckman.com. 3. Beckman Coulter, Inc., Diagnostic Division 130, avenue de Lattre de Tassigny, Marseille 13009, France. Electronic address: clejeune@beckman.com. 4. Beckman Coulter, Inc., Diagnostic Division, Chaska Campus 1000 Lake Hazeltine Drive, Chaska, MN 55318, United States. Electronic address: rjmasica@beckman.com. 5. Beckman Coulter, Inc., Diagnostic Division 130, avenue de Lattre de Tassigny, Marseille 13009, France. Electronic address: driviere@beckman.com. 6. Beckman Coulter, Inc., Diagnostic Division 130, avenue de Lattre de Tassigny, Marseille 13009, France. Electronic address: lnicouleau@beckman.com. 7. Beckman Coulter, Inc., Diagnostic Division 130, avenue de Lattre de Tassigny, Marseille 13009, France. Electronic address: pdenizot@beckman.com. 8. Beckman Coulter, Inc., Diagnostic Division 130, avenue de Lattre de Tassigny, Marseille 13009, France. Electronic address: pmarquet@beckman.com.
Abstract
OBJECTIVES: Anti-Müllerian hormone (AMH) measurement is useful as an aid in the evaluation of ovarian reserve. In the past, its conventional use was restricted by the low-throughput and variability of existing manual AMH assays. We developed the automated Access AMH assay for the quantitative determination of AMH levels on the Access family of immunoassay systems. The analytical performance of this new assay was evaluated. DESIGN AND METHODS: Sensitivity, dilution linearity, assay imprecision, AMH sample stability, lot-to-lot comparison and correlation with AMH Gen II assay (Beckman Coulter, Inc.) were evaluated. Reference intervals for Access AMH were established in healthy females, males, newborns (≤60days) and pediatric males classified by Tanner stages. RESULTS: The limit of blank and limit of detection were below 0.0077 and 0.0098ng/mL, respectively. The limit of quantitation was 0.010ng/mL. The total imprecision ranged from 2.4 to 5.2%. Linearity was observed up to 24ng/mL. Sample storage at room temperature up to 48h, at 2-8°C up to 7days and at -20°C up to 15months had no impact on measured AMH. The correlation study gave a coefficient between 0.99 and 1 and a regression slope between 0.89 and 0.92. Excellent lot-to-lot comparability was observed on controls and patient samples with a maximum bias of 3.7% between 2.81 and 15.03ng/mL. CONCLUSIONS: The fully automated Access AMH immunoassay demonstrates excellent analytical performance. As a consequence, the availability of this assay will represent a robust, fast and precise alternative to manual AMH assay testing.
OBJECTIVES: Anti-Müllerian hormone (AMH) measurement is useful as an aid in the evaluation of ovarian reserve. In the past, its conventional use was restricted by the low-throughput and variability of existing manual AMH assays. We developed the automated Access AMH assay for the quantitative determination of AMH levels on the Access family of immunoassay systems. The analytical performance of this new assay was evaluated. DESIGN AND METHODS: Sensitivity, dilution linearity, assay imprecision, AMH sample stability, lot-to-lot comparison and correlation with AMH Gen II assay (Beckman Coulter, Inc.) were evaluated. Reference intervals for Access AMH were established in healthy females, males, newborns (≤60days) and pediatric males classified by Tanner stages. RESULTS: The limit of blank and limit of detection were below 0.0077 and 0.0098ng/mL, respectively. The limit of quantitation was 0.010ng/mL. The total imprecision ranged from 2.4 to 5.2%. Linearity was observed up to 24ng/mL. Sample storage at room temperature up to 48h, at 2-8°C up to 7days and at -20°C up to 15months had no impact on measured AMH. The correlation study gave a coefficient between 0.99 and 1 and a regression slope between 0.89 and 0.92. Excellent lot-to-lot comparability was observed on controls and patient samples with a maximum bias of 3.7% between 2.81 and 15.03ng/mL. CONCLUSIONS: The fully automated Access AMH immunoassay demonstrates excellent analytical performance. As a consequence, the availability of this assay will represent a robust, fast and precise alternative to manual AMH assay testing.
Authors: Clarisa R Gracia; Sanghyuk S Shin; Maureen Prewitt; Janna S Chamberlin; Lori R Lofaro; Kristin L Jones; Marta Clendenin; Katherine E Manzanera; Dennis L Broyles Journal: J Assist Reprod Genet Date: 2018-03-14 Impact factor: 3.412
Authors: Rosalba Torrisi; Vera Basilico; Laura Giordano; Michele Caruso; Antonino Musolino; Marta Noemi Monari; Carlo Carnaghi; Armando Santoro Journal: Breast Care (Basel) Date: 2021-03-04 Impact factor: 2.860
Authors: Helen Jopling; Allen Yates; Nicholas Burgoyne; Katharine Hayden; Christopher Chaloner; Lesley Tetlow Journal: Endocrinol Diabetes Metab Date: 2018-07-18
Authors: Stamatina Iliodromiti; Barbara Salje; Didier Dewailly; Craig Fairburn; Renato Fanchin; Richard Fleming; Hang Wun Raymond Li; Krzysztof Lukaszuk; Ernest Hung Yu Ng; Pascal Pigny; Teddy Tadros; Joseph van Helden; Ralf Weiskirchen; Scott M Nelson Journal: Hum Reprod Date: 2017-08-01 Impact factor: 6.918